Drug profile · INN
metocurine iodide
METUBINE IODIDE
metocurine iodide (METUBINE IODIDE) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — metocurine iodide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
metocurine iodide (METUBINE IODIDE) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscle-type nicotinic acetylcholine receptor antagonist
Primary target: Muscle-type nicotinic acetylcholine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is metocurine iodide?
metocurine iodide (METUBINE IODIDE) is a muscle-type nicotinic acetylcholine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for metocurine iodide?
METUBINE IODIDE is a marketed brand name for metocurine iodide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metocurine iodide?
metocurine iodide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.